Vibeke Backer
Experienced in Hyperventilation

Vibeke Backer

Head & Neck Surgery, 
Copenhagen, DK 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Hyperventilation
Head & Neck Surgery, 
Copenhagen, DK 
OverviewLocationsClinical Research

Overview

Vibeke Backer practices in Copenhagen, Denmark. Backer is rated as an Experienced expert by MediFind in the treatment of Hyperventilation. Their top areas of expertise are Asthma, Allergic Rhinitis, Nasal Polyps, Endoscopy, and Hormone Replacement Therapy (HRT).

Their clinical research consists of co-authoring 313 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hyperventilation.

Locations

Head & Neck Surgery, Copenhagen, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Real-Life Chronic Rhinosinusitis Outcome Registry
Real-Life Chronic Rhinosinusitis Outcome Registry
Enrollment Status: Recruiting
Publish Date: February 13, 2025
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
Use of Omalizumab Will Increase the Pregnancy Rate, Proof of Concept Study, Where Women With Asthma and Infertility Will be Treated Three Times With Weight and IgE Balanced Dosis at the First Day of Their Period Bleeding
Use of Omalizumab Will Increase the Pregnancy Rate, Proof of Concept Study, Where Women With Asthma and Infertility Will be Treated Three Times With Weight and IgE Balanced Dosis at the First Day of Their Period Bleeding
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug
Study Drug: Omalizumab
Study Phase: Phase 2
Pharmacological Properties of Inhaled Salmeterol in Healthy Trained Males
Pharmacological Properties of Inhaled Salmeterol in Healthy Trained Males
Enrollment Status: Completed
Publish Date: January 31, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

313 Total Publications

Estimating the financial burden of asthma among young adults in Sweden.
Estimating the financial burden of asthma among young adults in Sweden.
Journal: European clinical respiratory journal
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Backer's expertise for a condition
ConditionClose
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile